Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-007777
Filing Date
2019-02-06
Accepted
2019-02-06 16:51:39
Documents
1
Period of Report
2019-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5889
  Complete submission text file 0001209191-19-007777.txt   7224
Mailing Address 3344 N. TORREY PINES COURT, SUITE 200 LA JOLLA CA 92037
Business Address
Hagan Joseph P (Reporting) CIK: 0001465278 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 19572091

Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations